Interactive panel discussion.

Open Access

Interactive panel discussion.

Session: SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Topic: Chronic Heart Failure

Speaker: Professor S. Anker (Berlin, DE) Professor A. Stewart Coats (Sydney, AU) Doctor D. Tomasoni (Brescia, IT) Professor G. Rosano (London, GB)

Organised by Charité Friends & Sponsors Trust

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speakers

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

179 presentations

16 followers

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

113 presentations

23 followers

Doctor Daniela Tomasoni

Spedali Civili, University Of Brescia, Brescia (Italy)

10 presentations

8 followers

Professor Giuseppe Rosano

St Georges Medical School, London (United Kingdom of Great Britain & Northern Ireland)

109 presentations

26 followers

5 more presentations in this session

Welcome and introduction.

Speaker: Professor S. Anker (Berlin, DE)

Access

Slides

Video

Optimizing foundational therapies in HF ‒ can we do better?

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access

Slides

Video

SGLT2 inhibition ‒ early, first-line therapy across the spectrum of HF.

Speaker: Doctor D. Tomasoni (Brescia, IT)

Access

Slides

Video

SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion.

Speaker: Professor G. Rosano (London, GB)

Access

Slides

Video

Conclusion.

Speaker: Professor C. Lam (Singapore, SG)

Access

Video

Access the full session

SGLT2 inhibition across the spectrum of heart failure: maximizing patient benefits in clinical practice

Speakers: Professor S. Anker, Professor A. Stewart Coats, Doctor D. Tomasoni, Professor G. Rosano, Professor S. Anker...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources